Akero Therapeutics Inc. (NASDAQ: AKRO) is one of the best mid cap pharma stocks to buy. On July 16, AstraZeneca announced ...

The inhaler, with an older propellant, is already approved in Europe for the treatment of adults with chronic obstructive ...

The agency has given a positive recommendation for a change in the gas propellant in Trixeo Aerosphere and Riltrava ...

This week's episode covers news about Sarepta, babies born following mitochondrial transfer, and AI identifying therapy ...

In this article, you’ll find some of the top content that was published on LCGC this week, including an ASMS 2025 retrospective and an overview of microplastic research.

AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.

Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, & Head of Development starting Aug 2025.

European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

Bristol Myers Squibb's chief medical officer, Samit Hirawat, is leaving the drugmaker to pursue new professional opportunities.

Another FTSE 100-listed ( ^FTSE) giant reporting in the week ahead is pharmaceuticals company AstraZeneca ( AZN.L ), which ...

With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...